menu search

Opgen announces closing of $7.5 million public offering

ROCKVILLE, Md., Jan. 11, 2023 (GLOBE NEWSWIRE) — OpGen, Inc. (Nasdaq: OPGN, “OpGen” or “the Company”), a precision medicine company harnessi...

January 11, 2023, 9:30 pm

Cathie wood makes this molecular diagnostics company top holding of ark invest's flagship fund, catapulting past zoom, tesla

Shares of Exact Sciences, Inc. EXAS have been on a tear, having gained over 27% in two sessions this week....

January 11, 2023, 11:19 am

Danaher (dhr) provides improved q4 core revenue growth guidance

Benefiting from strong growth in Cepheid's molecular diagnostics among other factors, Danaher (DHR) imp...

January 10, 2023, 2:18 pm

Kronos bio's stock rallies after announcing drug-discovery deal with roche

Shares of Kronos Bio Inc. KRON, +2.38% jumped 25% in premarket trading on Monday after the company announced a development deal with Roche Holding's R...

January 9, 2023, 8:23 am

molecular partners provides updates at 41st annual jpm healthcare conference

ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., Jan. 08, 2023 (GLOBE NEWSWIRE) — Ad hoc announcement pursuant to Art. 53 LR : ...

January 8, 2023, 8:00 pm

Opgen announces pricing of $7.5 million public offering

ROCKVILLE, Md., Jan. 06, 2023 (GLOBE NEWSWIRE) — OpGen, Inc. (Nasdaq: OPGN, “OpGen” or “the Company”), a precision medicine company harnessi...

January 7, 2023, 1:00 am

moleculin to present at the virtual investor 2023 companies to watch event

Live video webcast on Tuesday, January 17 th at 9:00 AM ET HOUSTON, Jan. 5, 2023 /PRNewswire/ --  mole...

January 5, 2023, 8:45 am

Revolutionizing protein sequencing: quantum-si's single-molecule technology

Quantum-Si's technology has potential in drug discovery and biomarker test development. The company's Platinum sequencing platform is set to launch....

January 4, 2023, 6:53 pm

4d molecular therapeutics: another gene therapy player with a differentiated profile

FDMT is an undercovered gene therapy developer. It claims certain competitive differences for its vector delivery platform....

January 3, 2023, 8:55 am

Ultra-high molecular weight polyethylene (uhmwpe) market size to surpass usd 3.4 billion by 2028 at 9.5% cagr – report by market research future (mrfr)

Ultra-High molecular Weight Polyethylene (UHMWPE) Market Insights and Industry Analysis by Form (Sheets...

January 2, 2023, 11:00 am

molecular partners to present at 41st annual jp morgan healthcare conference and swiss investor conferences

ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., Dec. 30, 2022 (GLOBE NEWSWIRE) — molecular Partners...

December 30, 2022, 6:00 am

molecular partners to present at 41st annual jp morgan healthcare conference and swiss investor conferences

ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., Dec. 30, 2022 (GLOBE NEWSWIRE) -- molecular Partners ...

December 30, 2022, 1:00 am

Htg molecular diagnostics provides highlights of its second event in drug discovery kol webcast series

TUCSON, Ariz., Dec. 28, 2022 (GLOBE NEWSWIRE) -- HTG molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), ...

December 28, 2022, 8:00 am

Terns announces closing of public offering of shares of common stock, including full exercise of underwriters’ option to purchase additional shares

FOSTER CITY, Calif., Dec. 23, 2022 (GLOBE NEWSWIRE) — Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stag...

December 23, 2022, 9:05 pm

Htg molecular diagnostics announces closing of a $10 million public offering

TUCSON, Ariz., Dec. 23, 2022 (GLOBE NEWSWIRE) — HTG molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG),...

December 23, 2022, 9:05 pm

Retirement weekly: don’t play whack-a-mole with your retirement investments

All types of investments will occasionally lag a reasonable benchmark. Read Full Story The post Retirement Weekly: Don’t play whack-a-...

December 23, 2022, 7:05 pm

Applied molecular transport announces top-line phase 2 results from lombard monotherapy trial of oral amt-101 in patients with moderate-to-severe ulcerative colitis

– Similar clinical remission rates observed in patients receiving AMT-101 monotherapy compared to placebo at week 12 – AMT-101 was well-tolerated ...

December 22, 2022, 10:30 pm

89bio: let's not give up already

ETNB went down after Madrigal's success. It has a NASH molecule with a different mechanism of action....

December 22, 2022, 8:34 am

Angion receives nasdaq notice regarding minimum bid price requirements

UNIONDALE, N.Y., Dec. 21, 2022 (GLOBE NEWSWIRE) — Angion Biomedica Corp (NASDAQ:ANGN), a biopharmaceutical company that has focused on the discovery...

December 22, 2022, 2:50 am

Htg molecular diagnostics announces pricing of a $10 million public offering

TUCSON, Ariz., Dec. 21, 2022 (GLOBE NEWSWIRE) — HTG molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG),...

December 21, 2022, 6:15 pm


Search within

Pages Search Results: